Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria

Clin J Am Soc Nephrol. 2022 Nov;17(11):1665-1668. doi: 10.2215/CJN.07290622. Epub 2022 Sep 9.
No abstract available

Keywords: CKD; SGLT2 inhibitor; dapagliflozin; microalbuminuria.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzhydryl Compounds / pharmacology
  • Benzhydryl Compounds / therapeutic use
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucosides* / pharmacology
  • Glucosides* / therapeutic use
  • Humans

Substances

  • dapagliflozin
  • Glucosides
  • Benzhydryl Compounds